Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Cash & Equivalents (2018 - 2025)

Evolus (EOLS) has disclosed Cash & Equivalents for 8 consecutive years, with $53.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents fell 38.1% year-over-year to $53.8 million, compared with a TTM value of $53.8 million through Dec 2025, down 38.1%, and an annual FY2025 reading of $53.8 million, down 38.1% over the prior year.
  • Cash & Equivalents was $53.8 million for Q4 2025 at Evolus, up from $43.5 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $146.3 million in Q4 2021 and bottomed at $22.2 million in Q1 2021.
  • Average Cash & Equivalents over 5 years is $74.1 million, with a median of $66.7 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents surged 381.13% in 2022, then crashed 70.5% in 2023.
  • Year by year, Cash & Equivalents stood at $146.3 million in 2021, then crashed by 63.13% to $53.9 million in 2022, then grew by 16.53% to $62.8 million in 2023, then skyrocketed by 38.37% to $87.0 million in 2024, then crashed by 38.1% to $53.8 million in 2025.
  • Business Quant data shows Cash & Equivalents for EOLS at $53.8 million in Q4 2025, $43.5 million in Q3 2025, and $61.7 million in Q2 2025.